Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Giles

Showing results (351-360 of 676) with videos related to

Pageof 68
Sort By:
Blood|September 25, 1999
Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemiaE H Estey, F J Giles, H Kantarjian, et al.
Leukemia & Lymphoma|May 30, 2001
Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phaseF J Giles, H Kantarjian, S O'Brien, et al.
Molecular Cancer Therapeutics|December 6, 2017
Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management SupportYoung Kwang Chae, Alan P Pan, Andrew A Davis, et al.
Experimental Hematology|May 9, 2009
Proteomics-based prediction of clinical response in acute myeloid leukemiaMaher Albitar, Steven J Potts, Francis J Giles, et al.
British Journal of Haematology|November 18, 2003
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemiaDeborah A Thomas, Elihu Estey, Francis J Giles, et al.
Genetic Testing|May 4, 2000
Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instabilityL C Williams, M R Hegde, R Nagappan, et al.
Blood|September 6, 2001
Phase 1 study of polyethylene glycol formulation of interferon alpha-2B (Schering 54031) in Philadelphia chromosome-positive chronic myelogenous leukemiaM Talpaz, S O'Brien, E Rose, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemiaYesid Alvarado, Apostolia Tsimberidou, Hagop Kantarjian, et al.
Leukemia|June 23, 2006
A novel translocation t(3;21)(p21;q22) in acute myelogenous leukemia preceding a late-appearing Philadelphia chromosomeA Quintás-Cardama, L V Abruzzo, F J Giles, et al.
Molecular & Cellular Proteomics : MCP|March 13, 2010
Proteomics analysis of bladder cancer exosomesJoanne L Welton, Sanjay Khanna, Peter J Giles, et al.
Pageof 68

Showing results (351-360 of 676) with videos related to

Sort By:
Pageof 68
Blood|September 25, 1999
Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemiaE H Estey, F J Giles, H Kantarjian, et al.
Leukemia & Lymphoma|May 30, 2001
Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phaseF J Giles, H Kantarjian, S O'Brien, et al.
Molecular Cancer Therapeutics|December 6, 2017
Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining "Actionability" of a Molecular Lesion and Patient Management SupportYoung Kwang Chae, Alan P Pan, Andrew A Davis, et al.
Experimental Hematology|May 9, 2009
Proteomics-based prediction of clinical response in acute myeloid leukemiaMaher Albitar, Steven J Potts, Francis J Giles, et al.
British Journal of Haematology|November 18, 2003
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemiaDeborah A Thomas, Elihu Estey, Francis J Giles, et al.
Genetic Testing|May 4, 2000
Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instabilityL C Williams, M R Hegde, R Nagappan, et al.
Blood|September 6, 2001
Phase 1 study of polyethylene glycol formulation of interferon alpha-2B (Schering 54031) in Philadelphia chromosome-positive chronic myelogenous leukemiaM Talpaz, S O'Brien, E Rose, et al.
Cancer Chemotherapy and Pharmacology|December 24, 2002
Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemiaYesid Alvarado, Apostolia Tsimberidou, Hagop Kantarjian, et al.
Leukemia|June 23, 2006
A novel translocation t(3;21)(p21;q22) in acute myelogenous leukemia preceding a late-appearing Philadelphia chromosomeA Quintás-Cardama, L V Abruzzo, F J Giles, et al.
Molecular & Cellular Proteomics : MCP|March 13, 2010
Proteomics analysis of bladder cancer exosomesJoanne L Welton, Sanjay Khanna, Peter J Giles, et al.
Pageof 68